Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis

PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation

(2012) Elizabeth Charytonowicz et al.   Clinical & Translational Oncology

FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma

(2012) L. E. S. Crose et al.   CLINICAL CANCER RESEARCH

PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis

(2011) A. D. Marshall et al.   CANCER RESEARCH

Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group

(2011) Jennifer L. Reichek et al.   CLINICAL CANCER RESEARCH

Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD

(2011) Hugo C. Olguín et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma

(2011) Amy D. Marshall et al.   MOLECULAR CARCINOGENESIS

Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer

(2010) L. Cao et al.   CANCER RESEARCH

IRIZIO : a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS)

(2010) Fabrizio Picchione et al.   CARCINOGENESIS

Fusion-Negative Alveolar Rhabdomyosarcoma: Modification of Risk Stratification Is Premature

(2010) James R. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Diagnosing Alveolar Rhabdomyosarcoma: Morphology Must Be Coupled With Fusion Confirmation

(2010) Leonard H. Wexler et al.   JOURNAL OF CLINICAL ONCOLOGY

Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

(2010) Daniel Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

2D-Difference Gel Electrophoretic Proteomic Analysis of a Cell Culture Model of Alveolar Rhabdomyosarcoma

(2010) Joseph G. Pressey et al.   JOURNAL OF PROTEOME RESEARCH

Regulation of Expression of Stromal-Derived Factor-1 Receptors: CXCR4 and CXCR7 in Human Rhabdomyosarcomas

(2010) M. Tarnowski et al.   MOLECULAR CANCER RESEARCH

National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing

(2010) Min H. Kang et al.   PEDIATRIC BLOOD & CANCER

High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human Myoblasts

(2009) Shujuan J. Xia et al.   AMERICAN JOURNAL OF PATHOLOGY

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

(2009) Elai Davicioni et al.   AMERICAN JOURNAL OF PATHOLOGY

Biomarker system for studying muscle, stem cells, and cancer in vivo

(2009) Koichi Nishijo et al.   FASEB JOURNAL

Diffuse Myogenin Expression by Immunohistochemistry is an Independent Marker of Poor Survival in Pediatric Rhabdomyosarcoma

(2008) Amy Heerema-McKenney et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations

(2008) Y.-X. Ren et al.   CANCER RESEARCH

Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma

(2008) S. Naini et al.   CANCER RESEARCH

Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma

(2008) F. Diomedi-Camassei et al.   CLINICAL CANCER RESEARCH

Molecular Characterization of the Pediatric Preclinical Testing Panel

(2008) G. Neale et al.   CLINICAL CANCER RESEARCH

Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus onMYCN as a biologically relevant target

(2008) Gabriela E. Mercado et al.   GENES CHROMOSOMES & CANCER

ALK Expression in Rhabdomyosarcomas: Correlation with Histologic Subtype and Fusion Status

(2008) Diana A. Corao et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma

(2007) Ken Kikuchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS